Why Investors Should Be Bullish on Biotech

Fundstrat Global Advisors research head Tom Lee discusses why investors should buy biotech with Bloomberg's Joe Weisenthal and Alix Steel on "What'd You Miss?" (Source: Bloomberg)

Morganlander Sees a 2018 Capital Investment Slowdown
12:35 - Chad Morganlander, portfolio manager at Washington Crossing Advisors, examines the impact of political uncertainty on companies' capital investment. He speaks on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • Fed Has No Explanation for Low Inflation, Says Dutta
  • A Deep Dive Into the Future of U.S.-China Trade
  • Rift Widens Between Trump and Business Leaders